Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J's prostate cancer drug proves promising in Ph2
J&J's prostate cancer drug proves promising in Ph2
J&J's prostate cancer drug proves promising in Ph2
Submitted by
admin
on February 17, 2010 - 6:54pm
Source:
Fierce Biotech
News Tags:
prostate cancer
JNJ
abiraterone
Headline:
J&J's prostate cancer drug proves promising in Ph2
Do Not Allow Advertisers to Use My Personal information
